Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuruhei Sukegawa

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|August 1, 2012
[Measures to reduce high-dose multiple antipsychotics in Japan]Tsuruhei Sukegawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 18, 2013
[Implementation of appropriate administration of antipsychotics--measures to reduce high-dose multiple antipsychotics]Tsuruhei Sukegawa
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|November 4, 2015
[Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia: The SCAP method]Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose methodYoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
International Journal of Psychiatry in Clinical Practice|June 20, 2014
Late-onset persistent visual hallucinations with epileptiform dischargeTsuyoshi Miyaoka, Rei Yasukawa, Tsuruhei Sukegawa, et al.
BMC Psychiatry|April 9, 2014
Study protocol: safety correction of high dose antipsychotic polypharmacy in JapanTsuruhei Sukegawa, Ataru Inagaki, Yoshio Yamanouchi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 12, 2005
Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disordersTsuyoshi Miyaoka, Rei Yasukawa, Hideaki Yasuda, et al.
Journal of Psychiatric Research|October 27, 2004
Proton magnetic resonance spectroscopy (1H-MRS) of hippocampus, basal ganglia, and vermis of cerebellum in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome)Tsuyoshi Miyaoka, Rei Yasukawa, Shoichi Mizuno, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 16, 2005
Fluid-attenuated inversion-recovery MR imaging in schizophrenia-associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome)Tsuyoshi Miyaoka, Rei Yasukawa, Takumi Mihara, et al.
International Clinical Psychopharmacology|April 19, 2003
Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitorsTsuyoshi Miyaoka, Rei Yasukawa, Ken Tsubouchi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|August 1, 2012
[Measures to reduce high-dose multiple antipsychotics in Japan]Tsuruhei Sukegawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 18, 2013
[Implementation of appropriate administration of antipsychotics--measures to reduce high-dose multiple antipsychotics]Tsuruhei Sukegawa
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|November 4, 2015
[Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia: The SCAP method]Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose methodYoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
International Journal of Psychiatry in Clinical Practice|June 20, 2014
Late-onset persistent visual hallucinations with epileptiform dischargeTsuyoshi Miyaoka, Rei Yasukawa, Tsuruhei Sukegawa, et al.
BMC Psychiatry|April 9, 2014
Study protocol: safety correction of high dose antipsychotic polypharmacy in JapanTsuruhei Sukegawa, Ataru Inagaki, Yoshio Yamanouchi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 12, 2005
Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disordersTsuyoshi Miyaoka, Rei Yasukawa, Hideaki Yasuda, et al.
Journal of Psychiatric Research|October 27, 2004
Proton magnetic resonance spectroscopy (1H-MRS) of hippocampus, basal ganglia, and vermis of cerebellum in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome)Tsuyoshi Miyaoka, Rei Yasukawa, Shoichi Mizuno, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 16, 2005
Fluid-attenuated inversion-recovery MR imaging in schizophrenia-associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome)Tsuyoshi Miyaoka, Rei Yasukawa, Takumi Mihara, et al.
International Clinical Psychopharmacology|April 19, 2003
Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitorsTsuyoshi Miyaoka, Rei Yasukawa, Ken Tsubouchi, et al.
Pageof 2